Folate analogue inhibitors of Leishmania major pteridine reductase (PTR1) are potential anti-parasitic drug candidates for combined therapy with dihydrofolate reductase (DHFR) inhibitors. To identify new molecules with specificity for PTR1, we carried out a virtual screening of the Available Chemicals Directory (ACD) database to select compounds that could interact with L. major PTR1 but not with human DHFR. Through two rounds of drug discovery, we successfully identified eighteen drug-like molecules with low micromolar affinities and high in vitro specificity profiles. Their efficacy against Leishmania species was studied in cultured cells of the promastigote stage, using the compounds both alone and in combination with 1 (pyrimethamine; 5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine). Six compounds showed efficacy only in combination. In toxicity tests against human fibroblasts, several compounds showed low toxicity. One compound, 5c (riluzole; 6-(trifluoromethoxy)-1,3-benzothiazol-2-ylamine), a known drug approved for CNS pathologies was active in combination and is suitable for early pre-clinical evaluation of its potential for label extension as a PTR1 inhibitor and anti-parasitic drug candidate.

Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase / Ferrari, Stefania; Morandi, Federica; Motiejunas, D.; Nerini, Erika; Henrich, S.; Luciani, Rosaria; Venturelli, Alberto; Lazzari, Sandra; Calo', Samuele; Gupta, S.; Hannaert, V.; Michels, P. A. M.; Wade, R. C.; Costi, Maria Paola. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 54:1(2011), pp. 211-221. [10.1021/jm1010572]

Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase

FERRARI, Stefania;MORANDI, federica;NERINI, Erika;LUCIANI, Rosaria;VENTURELLI, Alberto;LAZZARI, Sandra;CALO', Samuele;COSTI, Maria Paola
2011

Abstract

Folate analogue inhibitors of Leishmania major pteridine reductase (PTR1) are potential anti-parasitic drug candidates for combined therapy with dihydrofolate reductase (DHFR) inhibitors. To identify new molecules with specificity for PTR1, we carried out a virtual screening of the Available Chemicals Directory (ACD) database to select compounds that could interact with L. major PTR1 but not with human DHFR. Through two rounds of drug discovery, we successfully identified eighteen drug-like molecules with low micromolar affinities and high in vitro specificity profiles. Their efficacy against Leishmania species was studied in cultured cells of the promastigote stage, using the compounds both alone and in combination with 1 (pyrimethamine; 5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine). Six compounds showed efficacy only in combination. In toxicity tests against human fibroblasts, several compounds showed low toxicity. One compound, 5c (riluzole; 6-(trifluoromethoxy)-1,3-benzothiazol-2-ylamine), a known drug approved for CNS pathologies was active in combination and is suitable for early pre-clinical evaluation of its potential for label extension as a PTR1 inhibitor and anti-parasitic drug candidate.
54
1
211
221
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase / Ferrari, Stefania; Morandi, Federica; Motiejunas, D.; Nerini, Erika; Henrich, S.; Luciani, Rosaria; Venturelli, Alberto; Lazzari, Sandra; Calo', Samuele; Gupta, S.; Hannaert, V.; Michels, P. A. M.; Wade, R. C.; Costi, Maria Paola. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - STAMPA. - 54:1(2011), pp. 211-221. [10.1021/jm1010572]
Ferrari, Stefania; Morandi, Federica; Motiejunas, D.; Nerini, Erika; Henrich, S.; Luciani, Rosaria; Venturelli, Alberto; Lazzari, Sandra; Calo', Samuele; Gupta, S.; Hannaert, V.; Michels, P. A. M.; Wade, R. C.; Costi, Maria Paola
File in questo prodotto:
File Dimensione Formato  
jm1010572_2011.pdf

non disponibili

Descrizione: file pdf
Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 4.87 MB
Formato Adobe PDF
4.87 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/649244
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 57
social impact